TCL Archive Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events June 28, 2013
TCL Archive Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years May 9, 2014
TCL Archive ASCO Picks University of Michigan Medical School Dean Allen Lichter As Exective Vice President and CEO. July 14, 2006
TCL Archive NCI Programs to Average Eight Percent Increase Over ’87 Under House Total, Bit Some Would Vary August 14, 1987
